Pillstats
Rx only · Solution · Ophthalmic

Tobramycin

Tobramycin

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10627
US makers9 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.321$0.643$0.964$1.29Dec 2025Apr 2026Jul 2026
$1.118
Latest avg · Jul 22, 2026
+4%
Since Dec 17, 2025
9
Active US suppliers
30%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.8K18K26K35K2025 Q12025 Q22025 Q32025 Q42026 Q1
30K
Rx · 2026 Q1
159K
Units dispensed
+22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown2SUPPLYING
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown1SUPPLYING
Sandoz Incunknown1SUPPLYING
Sportpharm LLCunknown1SUPPLYING
Bausch & Lomb Incorporatedunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING
Asclemed USA, Inc.unknown1SUPPLYING
Preferred Pharmaceuticals Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.